Optical coherence tomography in the diagnosis of optic pathway gliomas.

PURPOSE To compare visual function assessment, optic disc evaluation by indirect ophthalmoscopy, and retinal nerve fiber layer analysis by optical coherence tomography (OCT) for the screening of optic pathway gliomas in pediatric patients (2-15 years old) affected by neurofibromatosis type 1. METHODS Fifty-seven consecutive patients with neurofibromatosis type 1 with recent (<6 months) orbital/brain magnetic resonance images (MRI) were included. Patients underwent visual function assessment (Hyvarinen symbols chart and/or Snellen charts) and optic disc evaluation by indirect ophthalmoscopy performed by experienced, masked pediatric ophthalmologists. Spectral domain OCT was performed to assess retinal nerve fiber layer. RESULTS Fifteen of 57 enrolled patients (26%) were affected by MRI-proven optic pathway gliomas. Visual function assessment, optic disc evaluation, and retinal nerve fiber layer analysis by OCT were feasible in 84%, 95%, and 88% of patients, respectively. Visual function assessment, retinal nerve fiber layer analysis, and optic disc evaluation results correlated with the presence of optic pathway gliomas (P = 0.007, P < 0.0001, and P = 0.03, respectively). Specificity and negative predictive value of each test were statistically significant in detecting optic pathway glioma (P < 0.0001), whereas only retinal nerve fiber layers analysis reached statistically significant sensitivity and positive predictive value (P = 0.0386). CONCLUSIONS Retinal nerve fiber layer analysis assessment using spectral domain OCT is superior to visual function assessment and optic disc evaluation as a clinical screening tool for optic pathway gliomas.

[1]  D. Gutmann,et al.  Modeling cognitive dysfunction in neurofibromatosis-1 , 2013, Trends in Neurosciences.

[2]  R. Packer,et al.  Feasibility and comparison of visual acuity testing methods in children with neurofibromatosis type 1 and/or optic pathway gliomas. , 2013, Investigative ophthalmology & visual science.

[3]  Yuquan Wen,et al.  Normative reference ranges for the retinal nerve fiber layer, macula, and retinal layer thicknesses in children. , 2013, American journal of ophthalmology.

[4]  K. North,et al.  The Impact of ADHD on the Cognitive and Academic Functioning of Children With NF1 , 2012, Developmental neuropsychology.

[5]  E. Pasmant,et al.  Neurofibromatosis type 1: from genotype to phenotype , 2012, Journal of Medical Genetics.

[6]  G. Quinn,et al.  Retinal nerve fiber layer thickness in children with optic pathway gliomas. , 2011, American journal of ophthalmology.

[7]  T. Young,et al.  Optical coherence tomography in the evaluation of neurofibromatosis type-1 subjects with optic pathway gliomas. , 2010, Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus.

[8]  J. Ortenberg,et al.  Optic pathway gliomas in patients with neurofibromatosis type 1: follow-up of 44 patients. , 2010, Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus.

[9]  S. Huson,et al.  Birth incidence and prevalence of tumor‐prone syndromes: Estimates from a UK family genetic register service , 2010, American journal of medical genetics. Part A.

[10]  S. Azen,et al.  Visual Acuity Norms in Pre-School Children: The Multi-Ethnic Pediatric Eye Disease Study , 2009, Optometry and vision science : official publication of the American Academy of Optometry.

[11]  C. Westall,et al.  Screening and diagnosis of optic pathway gliomas in children with neurofibromatosis type 1 by using sweep visual evoked potentials. , 2007, Investigative ophthalmology & visual science.

[12]  D. Gutmann,et al.  Optic pathway gliomas in neurofibromatosis‐1: Controversies and recommendations , 2007, Annals of neurology.

[13]  D. Evans,et al.  Guidelines for the diagnosis and management of individuals with neurofibromatosis 1 , 2006, Journal of Medical Genetics.

[14]  R. Hoffman,et al.  Can screening for optic nerve gliomas in patients with neurofibromatosis type I be performed with visual-evoked potential testing? , 2006, Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus.

[15]  W. Kaiser,et al.  Pediatric brain MRI in neurofibromatosis type I , 2005, European Radiology.

[16]  N. Miller,et al.  Primary tumours of the optic nerve and its sheath , 2004, Eye.

[17]  Y. Kalish,et al.  Swedish interactive thresholding algorithm fast for following visual fields in prepubertal idiopathic intracranial hypertension. , 2004, Ophthalmology (Rochester, Minn.).

[18]  G. Quinn,et al.  Threshold visual acuity testing of preschool children using the crowded HOTV and Lea Symbols acuity tests. , 2003, Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus.

[19]  L. Cyert Preschool Visual Acuity Screening with HOTV and Lea Symbols: Testability and Between-Test Agreement , 2003, Optometry and vision science : official publication of the American Academy of Optometry.

[20]  S. Blaser,et al.  Optic pathway glioma: correlation of imaging findings with the presence of neurofibromatosis. , 2001, AJNR. American journal of neuroradiology.

[21]  K. North,et al.  Optic gliomas in neurofibromatosis type 1: role of visual evoked potentials. , 1994, Pediatric neurology.

[22]  R. Chou,et al.  Screening for visual impairment in children ages 1-5 years: systematic review to update the 2004 U.S. preventive services task force recommendation , 2011 .

[23]  P. Phillips,et al.  Optic gliomas in neurofibromatosis type 1: role of visual evoked potentials. , 1995, Pediatric Neurology.